2-((2-dimethylaminobenzyl)sulfinyl)benzimidazole

Suppliers

Names

[ CAS No. ]:
100924-68-3

[ Name ]:
2-((2-dimethylaminobenzyl)sulfinyl)benzimidazole

[Synonym ]:
c16h17n3os

Chemical & Physical Properties

[ Density]:
1.34g/cm3

[ Boiling Point ]:
554.4ºC at 760mmHg

[ Molecular Formula ]:
C16H17N3OS

[ Molecular Weight ]:
299.39100

[ Flash Point ]:
289.1ºC

[ Exact Mass ]:
299.10900

[ PSA ]:
68.20000

[ LogP ]:
3.80240

[ Vapour Pressure ]:
2.47E-12mmHg at 25°C

[ Index of Refraction ]:
1.716

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CX9852500
CHEMICAL NAME :
Benzenamine, 2-((1H-benzimidazol-2-ylsulfinyl)methyl)-N,N-dimethyl -
CAS REGISTRY NUMBER :
100924-68-3
LAST UPDATED :
199706
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C16-H17-N3-O-S
MOLECULAR WEIGHT :
299.42

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #5037830
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
245 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #5037830
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #5037830
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
410 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #5037830

Related Compounds

  • Timoprazole
  • 1H-Benzimidazol-2-amine, N-(4,6-dimethyl-2-pyrimidinyl)-
  • 2-[(4-ethylsulfanyl-3-methylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole
  • 2-[(2-chlorophenyl)sulfinyl]ethyl phenyl sulfone
  • 2-[(2-methoxyphenyl)sulfinyl]ethyl phenyl sulfone
  • 2-(2-bromophenyl)-1H-benzimidazole
  • 5-chloro-3-methoxy-1H-indazole
  • methyl N-nitroso-N-pent-4-enylcarbamate
  • (3S,4R)-3-[(1S)-1-hydroxyethyl]-4-[(E)-2-phenylethenyl]azetidin-2-one
  • tert-Butyl 3-(1H-1,2,4-triazol-1-yl)propanoate
  • 1-(Benzyloxy)-4-(chloromethyl)-2-methylbenzene
  • ethyl N-[4-(piperidin-1-yl)but-2-yn-1-yl]carbamate
  • (E)-2'-DeschloroLuliconazole
  • 1,2,4,5-tetrachloro-3-(2,3,5,6-tetrachloro(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-trien-1-yl)(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-triene
  • 4-(3-Fluoro-4-methoxyphenyl)butanoic acid
  • N,N-Dimethyl-3-nitro-4-[2-(trimethylsilyl)ethynyl]benzenamine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.